Cardiac failure in diabetics: Taubman Institute brings leading expert to Ann Arbor March 15
Visiting Professor lecture series continues with Dr. E. Dale Abel
Dr. E. Dale Abel of the University of Utah School of Medicine will present two talks on the U-M campus on March 15, hosted by the Taubman Institute's Visiting Professor program and other U-M medical school departments.
Dr. Abel will speak about "Insulin Signaling and Cardiovascular Disease" at noon at the U-M Health System's Ford Auditorium as part of a grand rounds series.
At 2 p.m. he will presents "Molecular Insights into Diabetic Cardiomyopathy" in Room 5050 of the U-M Brehm Tower at 1000 Wall Street in Ann Arbor. This lecture is presented by the Endocrinology Research Seminar.
Dr. Abel, a professor of medicine, biochemistry and human genetics, also is the chief of the division of endocrinology, metabolism and diabetes at the University of Utah School of Medicine; the H.A. and Edna Benning Presidential Endowed Chair in Diabetes and Endocrinology and a senior investigator in the university's Program in Molecular Medicine.
The events are open to the public; no registration is required. CME credit is offered.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New Emerging Scholar named
Scott Tomlins, M.D., an assistant profesor of pathology at U-M, has been designated the A. Alfred Taubman Emerging Scholar. Dr. Tomlins is an expert in prostate cancer research.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.